ACT Biotech, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.actbiotech.com
Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2012-02-08
- Lead Sponsor
- ACT Biotech, Inc
- Target Recruit Count
- 48
- Registration Number
- NCT00952497
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸Central Georgia Cancer Care, P.C., Macon, Georgia, United States
🇺🇸University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States
News
No news found